Fingolimod Overcomes Lenalidomide Resistance in Multiple Myeloma by Inducing Ferroptosis
Fingolimod reverses lenalidomide resistance in multiple myeloma cells by suppressing the NRF2/SLC7A11/GPX4 axis and triggering ferroptosis.
Fingolimod reverses lenalidomide resistance in multiple myeloma cells by suppressing the NRF2/SLC7A11/GPX4 axis and triggering ferroptosis.
A pharmacovigilance analysis of over one million adverse event reports found disproportionate reporting signals for progressive multifocal leukoencephalopathy with natalizumab ...
A heat shock extract derived from soil-isolated Heyndrickxia coagulans reduced the effective inhibitory concentration of Fingolimod against HT-29 colorectal cancer ...
A new review argues that the atherogenic outcome of S1PR1 signalling depends on cell type, ligand presentation and inflammatory context ...
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.